Stocks and Investing Stocks and Investing
Wed, January 8, 2020
Tue, January 7, 2020

Matthew O"Brien Upgraded (ZBH) to Buy and Increased Target to $170 on, Jan 7th, 2020


Published on 2024-10-26 19:44:08 - WOPRAI, Matthew O'Brien
  Print publication without navigation


Matthew O"Brien of Piper Sandler, Upgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Buy and Increased Target from $140 to $170 on, Jan 7th, 2020.

Matthew has made no other calls on ZBH in the last 4 months.

There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 0 agree with Matthew"s Rating of Hold.

These are the ratings of the 8 analyists that currently disagree with Matthew;

Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $187 on, Thursday, December 19th, 2019
David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $170 on, Tuesday, December 17th, 2019
Lawrence Keusch of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $170 on, Wednesday, December 4th, 2019
Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $165 on, Wednesday, November 6th, 2019
Shagun Singh of "RBC Capital" Maintained at Buy with Increased Target to $155 on, Wednesday, November 6th, 2019
Ryan Zimmerman of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $158 on, Monday, October 7th, 2019
Kyle Rose of "Canaccord Genuity" Upgraded from Hold to Strong Buy and Increased Target to $167 on, Wednesday, September 18th, 2019
Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $158 on, Monday, September 9th, 2019

Contributing Sources